Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 GBX | -1.89% | -8.77% | -55.93% |
May. 20 | London gets boost thanks to rate cut hopes | AN |
May. 20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
Financials (USD)
Sales 2022 | - | Sales 2023 | 0.01 | Capitalization | 6.04M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -2M | EV / Sales 2022 | - |
Net cash position 2022 | 1.1M | Net cash position 2023 | 153K | EV / Sales 2023 | 612,941,875 x |
P/E ratio 2022 |
-4.57
x | P/E ratio 2023 |
-2.94
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.27% |
1 day | -1.89% | ||
1 week | -8.77% | ||
Current month | -11.86% | ||
1 month | -14.75% | ||
3 months | -31.58% | ||
6 months | -59.06% | ||
Current year | -55.93% |
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Chief Tech/Sci/R&D Officer | - | 22-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Kevin Cox
CHM | Chairman | 65 | 20-06-25 |
Director/Board Member | 57 | Apr. 21 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 2.6 | -1.89% | 387,964 |
24-06-13 | 2.65 | -1.85% | 184,817 |
24-06-12 | 2.7 | -3.57% | 161,292 |
24-06-11 | 2.8 | -1.75% | 208,394 |
24-06-10 | 2.85 | 0.00% | 765,967 |
Delayed Quote London S.E., June 14, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.93% | 4.36M | |
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- VAL Stock